Assessment of mediastinal tumors using SUVmax and volumetric parameters on FDG PET/CT

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 274

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JNMB-5-1_003

تاریخ نمایه سازی: 12 تیر 1398

Abstract:

Objective(s): This study aimed to evaluate the role of pretreatment SUVmax and volumetric FDG positron emission tomography (PET) parameters in the differentiation between benign and malignant mediastinal tumors. In addition, we investigated whether pretreatment SUVmax and volumetric FDG-PET parameters could distinguish thymomas from thymic carcinomas, and low-risk from high-risk thymomas.Methods: This study was conducted on 52 patients with mediastinal tumors undergoing FDG-PET/CT. Histological examination indicated that 29 mediastinal tumors were benign, and 23 cases were malignant. To obtain quantitative PET/CT parameters, we determined the maximum standardized uptake value (SUVmax), volumetric parameters, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for primary tumors using SUVmax cut-off value of 2.5. SUVmax, MTV and TLG of benign and malignant tumors were comparedusing the Mann-Whitney U test. Moreover, receiver-operating curve (ROC) analysis was applied to identify the cut-off values of SUVmax, MTV and TLG for the accurate differentiation of benign and malignant tumors. SUVmax, MTV and TLG were compared between thymomas and thymic carcinomas, as well as low-risk and high-risk thymomas.Results: Mean SUVmax, MTV and TLG of malignant mediastinal tumors were significantly higher compared to benign tumors (P<0.001). Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of SUVmax were 78.2%, 86.2%, 82.6%,81.8%, and 83.3%, respectively. These values were estimated at 82.6%, 96.6%, 90.4%,95%, and 87.5% for MTV and TLG, respectively. Additionally, optimal cut-off values for the differentiation of benign and malignant mediastinal tumors were determined at 4.2 and 22.3 mL and 79.7 g for SUVmax, MTV and TLG, respectively. Mean SUVmax, MTV and TLG of thymic carcinomas were significantly higher compared to thymomas (P<0.01), while no significant differences were observed in the mean quantitative parameters between low-risk and high-risk thymomas.Conclusion: Although SUVmax, MTV and TLG could not distinguish between low-risk and high-risk thymomas, these parameters might be able to differentiate benign tumors from malignant mediastinal tumors  noninvasively. These parameters could be used to distinguish between thymomas and thymic carcinomas as well. Therefore, FDG-PET/CT parameters seem to be accurate indices for the detection of malignant mediastinal tumors.

Authors

Takahiro Morita

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine

Mitsuaki Tatsumi

Department of Radiology, Osaka University Hospital

Mana Ishibashi

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine

Kayako Isohashi

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal ...
  • Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, ...
  • of 273 patients. Cancer. 2002;94(3):624-32. ...
  • Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, ...
  • J Surg Pathol. 2001;25(1):103-10. ...
  • Chen G, Marx A, Chen WH, Yong J, Puppe B, ...
  • Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, ...
  • Strollo DC, Rosado-de-Christenson ML, Jett JR. Primary mediastinal tumors: part ...
  • Landwehr P, Schulte O, Lackner K. MR imaging of the ...
  • Whitten CR, Khan S, Munneke GJ, Grubnic S. A diagnostic ...
  • Ahn JM, Lee KS, Goo JM, Song KS, Kim SJ, ...
  • Link KM, Samuels LJ, Reed JC, Loehr SP, Lesko NM. ...
  • Gamsu G, Stark DD, Webb WR, Moore EH, Sheldon PE. ...
  • Tomiyama N, Honda O, Tsubamoto M, Inoue A, Sumikawa H, ...
  • Kawashima A, Fishman EK, Kuhlman JE, Nixon MS. CT of ...
  • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST ...
  • Chen HH, Chiu NT, Su WC, Guo HR, Lee BF. ...
  • Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, ...
  • Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, ...
  • Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, ...
  • Kubota K, Yamada S, Kondo T, Yamada K, Fukuda H, ...
  • Luzzi L, Campione A, Gorla A, Vassallo G, Bianchi A, ...
  • mediastinal masses. Eur J Cardio-thorac Surg. 2009;36(3):475-9. ...
  • Hanamoto A, Tatsumi M, Takenaka Y, Hamasaki T, Yasui T, ...
  • Kao CH, Lin SC, Hsieh TC, Yen KY, Yang SN, ...
  • Chen SW, Chen WT, Wu YC, Yen KY, Hsieh TC, ...
  • Radiol. 2013;82(9):e405-10. ...
  • Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, ...
  • Igai H, Matsuura N, Tarumi S, Chang SS, Misaki N, ...
  • Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, ...
  • Lung Cancer. 2013;82(2):245-51. ...
  • Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, ...
  • Clin Oncol. 2010;28(23):3746-53. ...
  • Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, ...
  • Kumar A, Regmi SK, Dutta R, Kumar R, Gupta SD, ...
  • Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, ...
  • Boellaard R. Standards for PET image acquisition and quantitative data ...
  • Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of ...
  • نمایش کامل مراجع